LEADER 03972nam 2200601 450 001 9910463765203321 005 20200520144314.0 010 $a92-4-069279-7 035 $a(CKB)2670000000566901 035 $a(EBL)2046601 035 $a(SSID)ssj0001612850 035 $a(PQKBManifestationID)16338471 035 $a(PQKBTitleCode)TC0001612850 035 $a(PQKBWorkID)14913825 035 $a(PQKB)10075934 035 $a(MiAaPQ)EBC2046601 035 $a(Au-PeEL)EBL2046601 035 $a(CaPaEBR)ebr11199774 035 $a(OCoLC)909143583 035 $a(EXLCZ)992670000000566901 100 $a20150507h20132013 uy| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aWHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention 210 1$aGeneva :$cWorld Health Organization,$d[2013] 210 4$dİ2013 215 $a1 online resource (58 p.) 300 $a"WHO guidelines." 311 $a92-4-154869-X 320 $aIncludes bibliographical references. 327 $aCover; Contents; Lists of participants; Process for managing declarations and conflicts of interest; Acknowledgements; Acronyms and abbreviations; Executive summary; Screen-and-treat strategy summary recommendations; 1. Introduction; Target audience; Purpose; 2. Methods; Guideline groups; Formulating questions and determining outcomes; Synthesis of the evidence and preparation of evidence profiles; Modelling of health outcomes; Development of the recommendations; Guideline review and approval process; 3. Recommendations 327 $aImportant considerations that apply to all screen-and-treat recommendationsScreen-and-treat recommendations; 4. Research gaps and further considerations; 5. Use of the guideline; Guideline dissemination; Guideline evaluation; Guideline update; References; Annexes; Annex 1: Declarations of Interest; Annex 2: Decision-making flowchart for screen-and-treat strategies; Annex 3: Flowcharts for screen-and-treat strategies (negative or unknown HIV status); Screen with an HPV test and treat with cryotherapy or LEEP; Screen with an HPV test followed by VIA and treat with cryotherapy or LEEP 327 $aScreen with VIA and treat with cryotherapy or LEEPScreen with an HPV test followed by colposcopy (with or without biopsy) and treat with cryotherapy or LEEP; Screen with cytology followed by colposcopy (with or without biopsy) and treat with cryotherapy or LEEP; Annex 4: Flowcharts for screen-and-treat strategies (HIV-positive status or unknown HIV status in areas with high endemic HIV infection); Screen with an HPV test and treat with cryotherapy or LEEP; Screen with an HPV test followed by VIA and treat with cryotherapy or LEEP; Screen with VIA and treat with cryotherapy or LEEP 327 $aScreen with an HPV test followed by colposcopy (with or without biopsy) and treat with cryotherapy or LEEPScreen with cytology followed by colposcopy (with or without biopsy) and treat with cryotherapy or LEEP; Annex 5: Search strategies for evidence reviews; Annex 6: PRISMA flow diagram for inclusion and exclusion of studies for evidence reviews; Annex 7: Reference list of all studies included in the evidence reviews 606 $aCervix uteri$xPrecancerous conditions$xDiagnosis 606 $aCervix uteri$xDiseases$xDiagnosis 606 $aPrecancerous conditions$xDiagnosis 608 $aElectronic books. 615 0$aCervix uteri$xPrecancerous conditions$xDiagnosis. 615 0$aCervix uteri$xDiseases$xDiagnosis. 615 0$aPrecancerous conditions$xDiagnosis. 676 $a614.5999466 712 02$aWorld Health Organization, 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910463765203321 996 $aWHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention$92284386 997 $aUNINA